What is the pregnancy category for metoprolol?

Metoprolol is classified as a Category C medication during pregnancy. This classification indicates that animal reproduction studies have shown an adverse effect on the fetus, but there are no adequate and well-controlled studies in pregnant women. However, the potential benefits of using metoprolol may outweigh the risks in certain situations, such as managing severe hypertension or heart conditions in pregnant patients.

Understanding the implications of Category C is crucial for healthcare providers when prescribing medications during pregnancy. It signifies the need for caution and careful consideration of the risks versus benefits. In contrast, Category A drugs have been shown to be safe in controlled studies with pregnant women, while Category B indicates no risk in animal studies but a lack of adequate studies in humans. Category D drugs demonstrate evidence of risk to the fetus but may be used in life-threatening situations where no alternatives are available. This contextual understanding highlights the significance of the Category C classification for metoprolol and guides clinical decision-making for pregnant patients needing this therapy.